跳至主要内容
临床试验/NCT02368249
NCT02368249撤回2 期

Does Terlipressin Improve Renal Outcome After Liver Surgery - A Double-Blinded Randomized Control Trial (TIROL-Trial)

University of Zurich1 个研究点 分布在 1 个国家开始时间: 2020年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
serum creatinine peak level within 48 hours post-operative

研究概览

简要总结

The investigators aim to address whether terlipressin improves the renal outcome after liver surgery. Therefore the investigators are planning to conduct a double-blinded randomized control trial. The investigators will randomize patients undergoing any kind of liver surgery and being at increased moderate to high risk for post-operative acute renal failure into a control group receiving post- operative a placebo or into a group receiving post-operatively terlipressin in combination with human albumin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • >=12% risk for post-operative ARF on our recently developed and validated prediction score for ARF after liver surgery, patients will need five points or more in the pre-operative assessment of the predictors to be enrolled in the trial

排除标准

  • < 18 years
  • liver cirrhosis
  • coronary insufficiency with ST-elevation or ST-depression in the - - intra-operative ECG as signs of an acute coronary syndrome
  • pregnancy and breast feed

研究组 & 干预措施

Control Group

Placebo Comparator

Patients receiving post-operative placebo (Ringer lactate solution) treatment to preserve the renal function

干预措施: Placebo (Drug)

Terlipressin Group

Experimental

Patients receiving a post-operative intravenous terlipressin treatment in association with human albumin to preserve the renal function

干预措施: Terlipressin (Drug)

结局指标

主要结局

serum creatinine peak level within 48 hours post-operative

时间窗: within 48 hours post-operative

次要结局

  • Morbidity & mortality(Post Operative Day 0 - 14)
  • length of ICU stay(Post Operative Day 0 - 7)
  • the urinary output/24h(Post Operative Day 0 to 3)
  • Liver function(Post Operative Day 0 - 5)
  • length of hospital stay(Post Operative Day 0 - 14)
  • Need for hemofiltration and/or hemodialysis(Post Operative Day 0 - 14)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ksenija Slankamenac

MD PhD

University of Zurich

研究点 (1)

Loading locations...

相似试验